Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 594

1.

Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up.

Tan LK, Giri D, Hummer AJ, Panageas KS, Brogi E, Norton L, Hudis C, Borgen PI, Cody HS 3rd.

J Clin Oncol. 2008 Apr 10;26(11):1803-9. doi: 10.1200/JCO.2007.12.6425. Epub 2008 Mar 10.

PMID:
18332473
2.
3.

Sentinel node biopsy in ductal carcinoma in situ patients.

Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS.

Ann Surg Oncol. 2000 Jan-Feb;7(1):15-20.

PMID:
10674443
4.

Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.

Takeshita T, Tsuda H, Moriya T, Yamasaki T, Asakawa H, Ueda S, Sato K, Aida S, Tamai S, Matsubara O, Hase K, Yamamoto J.

Ann Surg Oncol. 2012 Apr;19(4):1160-6. doi: 10.1245/s10434-011-2085-5. Epub 2011 Oct 12.

PMID:
21989659
5.

Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.

Loya A, Guray M, Hennessy BT, Middleton LP, Buchholz TA, Valero V, Sahin AA.

Cancer. 2009 Apr 15;115(8):1605-12. doi: 10.1002/cncr.24173.

6.

Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.

Kahn HJ, Hanna WM, Chapman JA, Trudeau ME, Lickley HL, Mobbs BG, Murray D, Pritchard KI, Sawka CA, McCready DR, Marks A.

Breast J. 2006 Jul-Aug;12(4):294-301.

PMID:
16848838
7.

Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.

Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA.

Am J Surg Pathol. 2000 Sep;24(9):1266-72.

PMID:
10976701
8.

Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.

Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.

Ann Surg Oncol. 2009 Dec;16(12):3366-74. doi: 10.1245/s10434-009-0660-9. Epub 2009 Sep 4.

PMID:
19760047
9.

Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.

Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.

J Surg Oncol. 2004 Oct 1;88(1):4-7; discussion 7-8.

PMID:
15384064
11.

Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.

Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, Liberman L, Turner RR, Lagios MD, Cody Iii HS, Giuliano AE, Silverstein MJ, Van Zee KJ.

Ann Surg Oncol. 2007 Oct;14(10):2911-7. Epub 2007 Jun 28.

PMID:
17597346
12.
13.

Does the method of biopsy affect the incidence of sentinel lymph node metastases?

Newman EL, Kahn A, Diehl KM, Cimmino VM, Kleer CA, Chang AE, Newman LA, Sabel MS.

Breast J. 2006 Jan-Feb;12(1):53-7.

14.
15.

The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy.

Dupont EL, Kuhn MA, McCann C, Salud C, Spanton JL, Cox CE.

Am J Surg. 2000 Oct;180(4):274-7.

PMID:
11113434
16.

Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence.

Pernas S, Gil M, Benítez A, Bajen MT, Climent F, Pla MJ, Benito E, Guma A, Gutierrez C, Pisa A, Urruticoechea A, Pérez J, Gil Gil M.

Ann Surg Oncol. 2010 Mar;17(3):772-7.

PMID:
20183912
17.

Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.

Beriwal S, Soran A, Kocer B, Wilson JW, Ahrendt GM, Johnson R.

Am J Clin Oncol. 2008 Feb;31(1):34-8. doi: 10.1097/COC.0b013e318068419b.

PMID:
18376225
18.

Histopathologic analysis of sentinel lymph nodes in breast carcinoma.

Hsieh PP, Ho WL, Yeh DC, Liu TJ, Wu CC, Lin JH, Wang SJ.

Zhonghua Yi Xue Za Zhi (Taipei). 2000 Oct;63(10):744-50.

PMID:
11076431
19.

Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation.

Stranzl H, Mayer R, Ofner P, Peintinger F, Prettenhofer U, Hackl A.

Strahlenther Onkol. 2004 Jan;180(1):31-7.

PMID:
14704842
20.

Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.

Pugliese MS, Beatty JD, Tickman RJ, Allison KH, Atwood MK, Szymonifka J, Arthurs ZM, Huynh PP, Dawson JH.

Ann Surg Oncol. 2009 Jan;16(1):113-20. doi: 10.1245/s10434-008-0121-x. Epub 2008 Oct 23.

PMID:
18949520

Supplemental Content

Support Center